Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)

Tomoko Horinouchi(Kobe University), Kazumoto Iijima(Kobe Children's Hospital), Koichi Nakanishi(University of the Ryukyus), Shuichi Ito(Yokohama City University), Kenji Ishikura(Kitasato University), Mari S. Oba(Yokohama City University), Kandai Nozu(Kobe Children's Hospital), Mayumi Sako(National Center For Child Health and Development), Hidefumi Nakamura(National Center For Child Health and Development)
BMC Nephrology
November 1, 2018
Cited by 12


Related Papers